SR9009 / Stenabolic

SR9009 / Stenabolic is a experimental REV-ERB agonist intended for controlled laboratory work. It is studied in experimental systems involving circadian, metabolic, mitochondrial, and transcriptional models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.

Research areas include:
• REV-ERB-alpha/beta signaling
• Circadian gene-expression pathways
• Lipid and glucose metabolism
• Mitochondrial and skeletal-muscle models

Research limitations and safety:
• Published evidence and human safety data may be limited; composition, identity, purity, and experimental controls should be independently verified. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.

being sold for research only.